Views: 289 Author: ZHENYIBIO Publish Time: 2026-10-02 Origin: Site
Content Menu
● Selection Criteria and Technical Checks
>> How the shortlist was assessed
>> Specify the material before requesting prices
● Ten China-Based Sourcing Leads
>> Capacity, MOQ and certification comparison
>> 1. ZHENYIBIO TECHNOLOGY INC — flexible formulation support
>> 2. TNJ Chemical — specification-led bulk inquiry
>> 3. Ningbo Hi-Tech Zone Yefeng New Materials Technology Co., Ltd. — composition-focused qualification
>> 4. Ningbo Inno Pharmchem Co., Ltd. — integrated sourcing platform
>> 5. Xi'an Aogu Biotech Co., Ltd. — a C10-only inquiry lead
>> 6. Watson Biotechnology Co., Ltd. — catalogue sourcing for evaluation
>> 7. Mainchem Co., Ltd. — drum-scale sourcing lead
>> 8. Shanghai Wencai New Material Technology Co., Ltd. — small-package sourcing lead
>> 9. Hubei Xinjiecheng Chemical Technology Co., Ltd. — quotation comparison lead
>> 10. Taizhou Shikang Pharmaceutical Technology Co., Ltd. — analytical documentation lead
● The less-visible substitution risk
● FAQs
>> 1. How can we tell whether a supplier's ISO certificate has expired or covers the wrong facility?
>> 3. What does an apparently high "purity" figure fail to tell us?
>> 5. What should we do when a supplier offers OEM/ODM support but cannot identify the ester plant?
A purchasing decision for Propylene Glycol Dicaprate starts with an unusually important question: Is the supplier quoting the ingredient you actually specified? Propylene Glycol Dicaprate is the diester of propylene glycol and capric acid. Propylene Glycol Dicaprylate/Dicaprate is a different ingredient—a mixture of propylene glycol diesters of caprylic and capric acids. The Cosmetic Ingredient Review identifies them separately and lists different CAS numbers for each. A supplier's listing for the mixed C8/C10 ester should therefore not be treated as proof that it produces the C10-only material.
China offers international buyers a broad network of cosmetic-ingredient developers, chemical processors, distributors and export-service companies. Its scale is relevant, but market size is not evidence of capacity for this particular ester. China's National Bureau of Statistics reported cosmetics retail sales of 465.3 billion yuan in 2025, up 5.1% year on year. A separate industry report valued China's *personal care ingredients* market at approximately US$1.74 billion in 2025; neither figure measures Propylene Glycol Dicaprate production.
Regional networks can make sourcing and formulation work easier. A 2025 Guangzhou industry white paper, as reported at the time, described a cosmetics ecosystem spanning ingredient research, manufacturing, packaging and brand services. Shanghai's Qingpu district likewise describes a supply chain linking raw-material research with manufacturing and commercialization. These are reasons to investigate a region—not substitutes for auditing the named production site.
For overseas brands, wholesalers and contract manufacturers, the practical opportunity is to find a partner that can document the correct ingredient, repeat its quality from lot to lot and communicate reliably when a formulation or delivery schedule changes. This guide treats the ten companies as sourcing leads for qualification, with clear limits on what their public information proves.
The companies were screened for a public listing of Propylene Glycol Dicaprate or the closely related Propylene Glycol Dicaprylate/Dicaprate, plus evidence relevant to an international cosmetic-ingredient buyer. The assessment gives weight to five questions:
1. Ingredient identity: Does the listing name the C10-only ingredient, or only the mixed C8/C10 ester? Can the company supply a product-specific specification and batch certificate of analysis?
2. Manufacturing responsibility: Who owns or operates the esterification and finishing line? Can the seller identify the manufacturing site, legal entity and batch-release authority?
3. Quality controls: Are acid value, water, colour, fatty-acid composition and relevant residuals controlled by stated methods and limits?
4. Commercial reliability: Can the company document realistic capacity, minimum order quantity (MOQ), sample availability, lead time and packaging?
5. Customization and export support: Can it support formulation trials, packaging changes or finished-product original equipment manufacturing/original design manufacturing (OEM/ODM) without confusing those services with manufacture of the ester itself?
This is not a verified league table of ten C10-only factories. Public evidence is stronger for some companies' mixed-ester offerings than for their C10-only production, and several directory entries identify the seller as a trader or service provider. A buyer should use the list to decide whom to investigate, then award business on audited evidence.
2222
These identities and CAS listings come from the Cosmetic Ingredient Review assessment; a buyer should still confirm the identifier used on the specific supplier's current safety data sheet and regulatory documents.
A useful reference point for the C10-only material is NIKKOL's publicly listed Propylene Glycol Dicaprate: it describes a capric-acid/propylene-glycol diester and discusses its light feel and solvent properties. NIKKOL is a technical reference here, not one of the China-based companies ranked below.
For either ingredient, request a technical data sheet and a certificate of analysis (COA) from the proposed commercial lot. A buyer's specification should set agreed limits and methods for appearance, colour, acid value, water and, where relevant, fatty-acid composition, residual starting materials and odour. Do not copy one seller's numbers into a universal standard: the correct limits depend on the agreed grade, test method and formulation. Yefeng's published mixed-ester listing, for example, provides values for colour, acid value, water and C8/C10 composition that are useful as quotation-specific comparison points.
For sustainability claims, ask which part of the feedstock is plant-derived and obtain traceability documents. If palm-derived fatty acids are involved, distinguish RSPO Identity Preserved, Segregated, Mass Balance and Credits; those models support different claims. A general statement that an ingredient is "plant-derived" does not identify its supply-chain model.
Finally, screen out irrelevant compliance badges. CE marking applies only to product categories covered by EU rules that require it, while the EU RoHS directive concerns electrical and electronic equipment. Neither is a meaningful default certification for a drum of cosmetic ester. EU buyers instead need the ingredient identity and safety information required to assess their *finished cosmetic product*.
"Not publicly stated" is a deliberate result, not an estimate. Published package sizes and company-wide facilities must not be mistaken for a product-specific MOQ or annual ester capacity. Certifications in company materials are claims to verify for the named legal entity, site, scope and validity period.
1111
The table reflects the reviewed company pages and supplier directories, not completed factory audits. A package listing indicates a possible sales format, not available stock, an accepted order quantity or control of manufacture.
Established: 2012, according to its company profile. Main markets: The company says it sells into more than 50 countries, including markets in Asia, Europe and the Americas. Core strength: A cosmetic-ingredient portfolio, research facilities and an export-facing service model that may appeal to smaller brands managing several actives and formulation projects at once.
ZHENYIBIO describes a 10,000 m² production area and a 1,500 m² research centre. Its profile focuses on ingredients including glutathione, hyaluronic acid, polyglutamic acid, asiaticoside, peptides and liposomes. The company also publishes a page for Propylene Glycol Dicaprylate/Dicaprate, the mixed ester. That page describes esterification and refining, but it does not establish publicly available capacity, MOQ or a separately documented Propylene Glycol Dicaprate C10-only grade. Buyers should request the precise INCI name, production-site details and a recent batch COA before treating the two as interchangeable.
For an emerging brand, the company's plausible advantage is coordinated communication across ingredient supply and formulation development—not a proven lowest price. Discuss small-run packaging, sample-to-bulk continuity, customization milestones and who will answer technical questions during scale-up. Its publicly described formulation guidance could be useful for a brand combining an emollient with plant actives, provided the contracted OEM/ODM deliverables are specified in writing. Verify: whether the ester is produced at a ZHENYIBIO-controlled site or sourced from another manufacturer, and which certificates cover that site and product.
Established: TNJ's company history says three chemists established it in 2001. Main-market orientation: Its materials describe chemical manufacturing, international trade and service. Core strength: A relatively detailed public listing for the mixed ester, including a claimed assay of at least 99.5%, a stated water limit and 200 kg/drum packaging. Those figures provide concrete questions for an initial technical inquiry, but remain seller-published claims until supported by a current lot COA.
TNJ is a sensible contact for a buyer seeking a documented mixed C8/C10 ester or a broader chemical sourcing relationship. Its company description explicitly combines manufacturing with trading; procurement should therefore identify the actual plant for the quoted lot, not assume every catalogue item is made in-house. For OEM/ODM, ask separately whether TNJ offers a defined custom ingredient grade, a formulation service or simply export and packaging support. Verify: current manufacturing entity, method behind the assay figure and certificate scope.
Established: 2012, according to its marketplace company description. Main-market orientation: It describes cosmetic, pharmaceutical and food-additive export activity and says it can assist with some formulations and testing. Core strength: Its mixed-ester product listing provides a more useful starting specification than many catalogue pages: appearance, colour, acid value, water and a stated C8/C10 fatty-acid distribution. It also lists 180 kg/drum packaging.
That composition detail matters for buyers replacing an incumbent emollient: two products sold under the mixed-ester INCI name can still require a sensory and stability check in the finished formula. Treat Yefeng's formulation and testing descriptions as prospective services to define in an RFQ, not as evidence of a complete finished-cosmetic OEM/ODM programme. Verify: analytical methods, batch-to-batch composition range, plant identity, actual MOQ and lead time.
Established: 2007, according to its company profile. Main-market orientation: Fine chemicals and pharmaceutical intermediates, with a stated supply-chain and international commercial focus. Core strength: The company describes research, pilot work and partnered commercial manufacturing assets, while also publishing information about the mixed C8/C10 ester. This may suit a buyer whose programme needs more than a spot purchase—for example, technical sourcing coordination across several specialty ingredients.
Its description of a "virtual" manufacturing network makes the audit question particularly clear: which legal entity and plant will produce this ester? General platform capability is not an annual capacity figure for a named product. Likewise, do not infer that its continuous-flow equipment is used to make this ester without a process-specific statement. Verify: the proposed plant, batch-release responsibility, product-specific capacity and which customization services are contractually offered.
Established/history: Its company story says it has supplied superfoods since 2014, although that statement should not be read as a verified incorporation date. Main markets: The company story discusses USA and UK activity for one of its brands and describes a cosmetics raw-material brand. Core strength: A public page specifically advertising Propylene Glycol Dicaprate, rather than only the mixed ester, makes it worth contacting when the C10-only ingredient is non-negotiable.
The key distinction remains unproved until Aogu supplies a current product specification and traceable lot documents. Its broader story describes sourcing, warehousing, wholesale and white-label support; it does not, by itself, prove ownership of a Propylene Glycol Dicaprate esterification line. For OEM/ODM discussions, establish whether the proposed service is ingredient sourcing, private-label finished products or custom manufacture at a named partner facility. Verify: identity, plant, COA, MOQ and relevant certification.
Established: Not established in the reviewed public supplier listing. Main markets: Export coverage is not substantiated there. Core strength: Watson appears in supplier listings for Propylene Glycol Dicaprylate/Dicaprate; one listing shows a 25 kg package and a claimed 99% purity. The directory identifies it as a trader, so it is more accurately an evaluation lead than a verified manufacturer of this ester.
A 25 kg listing may be convenient for development work, but it is not a confirmed MOQ. Ask Watson to name the original manufacturer, provide the manufacturer-issued COA and explain whether trial and commercial lots will come from the same site. No product-specific OEM/ODM capability is established by the reviewed listing; request a written scope if such support is offered.
Established: Not established in the reviewed listing. Main markets: Not established there. Core strength: Its mixed-ester directory entry lists a 180 kg drum, a format relevant to buyers planning larger trials or routine replenishment. The same directory classifies Mainchem as a trader, not as an audited ester producer.
For a buyer comparing delivered cost, the drum listing is a useful opening for questions about packaging, lot size and shipping documentation—not proof that 180 kg is the minimum purchasable amount or immediately available. Ask for the producing plant's name, a current COA, a sample from the offered lot and the scope of any repacking or custom-label service. Product-specific OEM/ODM and certifications remain unverified.
Established: Not established in the reviewed directory. Main markets: Not established there. Core strength: Its mixed-ester entry lists multiple pack sizes, from small laboratory quantities to 25 kg, and identifies the company as a service provider. That makes it a possible contact for screening material before a full-scale supplier audit.
A formulator may find small packages useful when comparing sensory properties or solvent performance. The procurement risk is assuming that a laboratory sample represents a stable commercial supply chain. Ask who made each sample, whether the same manufacturer will supply bulk orders, and how lot identity is preserved if Wencai repacks material. Neither manufacturing ownership nor finished-product OEM/ODM is established by the listing.
Established: Not established in the reviewed public entry. Main markets: Not established there. Core strength: A mixed-ester listing with several package options gives buyers a contact for comparing quotations at different order scales. The directory classifies the company as a trader; advertised package options should not be read as verified MOQ, inventory or plant output.
Use the inquiry to test quotation discipline: can the seller provide the same INCI, CAS reference, manufacturing site and specification on its sample label, COA and pro forma invoice? Ask whether any custom pack size or ingredient-grade change is offered by the originating factory. No product-specific OEM/ODM scope or certificate has been established in the reviewed entry.
Established: Not established in the reviewed listing. Main markets: Not established there. Core strength: Its directory entry for the mixed ester mentions GC, a claimed purity figure and package sizes extending from a small sample to 25 kg. The listing also classifies the company as a trader.
For a technically demanding buyer, the useful first question is not whether a catalogue says "GC," but what the method measures and whether a lot-specific chromatogram is available. Ask who performed the test, which fatty-acid components were identified and how the sample links to a commercial batch. Treat any stated standard or grade in a marketplace entry as a claim to document—not an approval of the ingredient for a different application. Product-specific OEM/ODM remains unverified.
The procurement trap is often not an obviously poor-quality drum. It is a plausible-looking, misidentified one. A quote headed "Propylene Glycol Dicaprate" may be supported by paperwork for Propylene Glycol Dicaprylate/Dicaprate, or even for plain propylene glycol. That error can survive a price comparison because the names overlap, while the proposed materials do not have the same identity. The Cosmetic Ingredient Review lists the C10-only and mixed C8/C10 esters separately; a listing encountered during this research also carried a "dicaprate" heading while describing plain propylene glycol with CAS 57-55-6.
A disciplined buyer checks four matching records before approving a sample: purchase specification, sample label, safety data sheet and batch COA. Each should identify the same material. For a mixed ester, compare the agreed C8/C10 profile; for a C10-only order, require evidence that the proposed lot matches the C10-focused specification. Do not rely on an attractive assay percentage alone if the assay's definition and method are unclear.
Use this qualification sequence:
1. Issue one precise RFQ. State the required INCI, acceptable CAS identification, intended cosmetic application, annual forecast, trial quantity, destination country, packaging and required documents. Invite suppliers to flag any proposed alternative as an alternative—not quote it under the original name.
2. Identify the production chain. Request the manufacturer's legal name, plant address and role of every intermediary. Ask who esterifies, finishes, tests, releases and exports the lot.
3. Review documents before samples. Obtain a current specification, safety data sheet, representative COA, certificate copies where claimed, feedstock-origin statement and a written shelf-life/storage recommendation.
4. Test a traceable sample. Ask for a labelled sample from an identified production lot. Compare identity and critical values with the supplier's COA, then evaluate appearance, odour and performance in the intended formulation.
5. Approve a commercial lot conditionally. Set acceptance limits, sampling rules, retained-sample requirements and a change-notification clause covering feedstock, plant or process changes.
6. Confirm delivery terms. Put the agreed Incoterm, pack size, drum identification, document set, insurance responsibility and claims procedure on the purchase order. Ask the freight forwarder to review the current safety data sheet rather than assuming every cosmetic ester has the same transport classification.
For a long-term programme, shortlist by verified ingredient identity first, then compare batch consistency, production responsibility, responsive technical support and delivered cost. ZHENYIBIO may be a practical first conversation for a smaller brand seeking coordinated ingredient and formulation assistance, but its publicly listed product is the mixed C8/C10 ester; a C10-only requirement needs separate confirmation. The same standard applies to every company in this guide: request the current specification, traceable sample, plant details and valid site-specific documents before awarding supply.
To begin a quotation with ZHENYIBIO, send its team your target INCI, intended formulation, trial volume, expected annual demand and destination market through its. Ask explicitly whether it can supply Propylene Glycol Dicaprate, Propylene Glycol Dicaprylate/Dicaprate, or both, and request the corresponding lot documentation.
Ask for the full certificate, including certificate number, issuing body, accredited standard, scope, site address, issue date and expiry date. Search the relevant accredited-certification database or contact the issuing certification body directly. A valid corporate certificate for one address does not automatically cover another plant or prove that this ester is within its scope. ISO itself does not issue company certificates.
Only through a controlled formulation change. They are separately identified ingredients, so first obtain the proposed material's correct INCI and documentation. Then repeat the relevant sensory, stability, compatibility and finished-product review before changing purchasing specifications or labels. A supplier's statement that the two "perform the same" is not enough.
Unless the seller defines the analytical method and what counts toward the result, a single percentage cannot establish the fatty-acid distribution, residual starting materials, water content, colour or odour of the material you will receive. Ask for the test method, chromatogram where relevant and agreed limits for the properties that affect your formulation. Yefeng's listing illustrates why a mixed ester needs composition information alongside other quality parameters.
No. RSPO recognizes distinct sourcing models, including Segregated and Mass Balance. Ask which model applies to the quoted product, whether the relevant facility and transaction are covered, and what claim your brand can accurately make. Do not convert a Mass Balance sourcing statement into a claim of physical segregation.
Separate the contracts and responsibilities. Define whether the service covers ingredient sourcing, a customized ingredient grade, formulation development, finished-product manufacture, packaging or regulatory-document coordination. Require the original ester manufacturer to be identified for lot traceability, and specify who investigates complaints and authorizes changes. A seller can provide useful design or export support without being the producer of every ingredient it sells; the risk comes from leaving that distinction undocumented.
- [Cosmetic Ingredient Review: safety assessment of propylene glycol esters] — ingredient definitions and the distinction between the C10-only and mixed esters. [cir-safety]
- [National Bureau of Statistics of China: 2025 retail sales] — official cosmetics retail data; not an ester production or export figure. [stats.gov]
- [National Medical Products Administration: cosmetics policy interpretation] — ingredient innovation and quality-management context. [english.nmpa.gov]
- [MarketsandMarkets: China personal care ingredients market] — 2025 market estimate and forecast for the broader ingredient category; not a Propylene Glycol Dicaprate market-size estimate. [marketsandmarkets]
- [European Commission: CosIng] — cosmetic-ingredient information database; its entries alone do not determine regulatory compliance. [ec.europa]
- [ISO: certification and certificate verification] — how to check management-system claims and issuing bodies. [iso]
- [RSPO: supply-chain models] — distinctions between palm-derived material sourcing claims. [rspo]